Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)-Reference-Cited by-同舟云学术

Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)

Published:2018-06-15 Issue:1 Volume:18 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Braat Arthur J. A. T.^ORCID,Kwekkeboom Dik J.,Kam Boen L. R.,Teunissen Jaap J. M.,de Herder Wouter W.,Dreijerink Koen M. A.,van Rooij Rob,Krijger Gerard C.,de Jong Hugo W. A. M.,van den Bosch Maurice A. A. J.,Lam Marnix G. E. H.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12876-018-0817-8.pdf

Reference48 articles.

1. Bosman FT, Carneiro F. World Health Organization classification of Tumours, pathology and genetics of Tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010.

2. Capelli P, Fassan M, Scarpa A. Pathology - grading and staging of GEP-NETs. Best Pract Res Clin Gastroenterol. 2012;26(6):705–17.

3. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063–72.

4. Pavel MBE, Couvelard A, et al. ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinol. 2012;95(2):157–76.

5. Fraenkel M, Kim MK, Faggiano A, Valk GD. Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol. 2012;26(6):691–703.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic Radioembolization;PET Clinics;2024-07

2. Dose–effect relationships in neuroendocrine tumour liver metastases treated with [166Ho]-radioembolization;European Journal of Nuclear Medicine and Molecular Imaging;2024-02-19

3. Management of neuroendocrine tumor liver metastases;The American Journal of Surgery;2023-11

4. Developments in interventional management of hepatic metastases from neuroendocrine tumours;Best Practice & Research Clinical Endocrinology & Metabolism;2023-09

5. Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry;EJNMMI Research;2023-07-15